Učitavanje...
Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
T-cells genetically engineered to express a chimeric antigen receptor (CAR) have shown remarkable results in patients with B-cell malignancies, including B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and mantle cell lymphoma, with some promising efficacy in patients with multip...
Spremljeno u:
| Izdano u: | Front Immunol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902760/ https://ncbi.nlm.nih.gov/pubmed/33643299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.618387 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|